Faron Pharmaceuticals Oy (AIM:FARN)
London · Delayed Price · Currency is GBP · Price in GBX 39.00
+3.50 (9.86%)
Sep 25, 2026, 10:38 AM GMT
Faron Pharmaceuticals Oy Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -16.34 | -27.26 | -25.92 | -30.94 | -28.73 | -21.19 |
Depreciation & Amortization | 0.34 | 0.33 | 0.31 | 0.35 | 0.3 | 0.31 |
Stock-Based Compensation | 1.71 | 1.82 | 0.69 | 2.45 | 1.3 | 1.49 |
Other Operating Activities | -2.93 | 6.99 | 7.21 | 1.1 | -0.63 | -1.06 |
Change in Accounts Payable | -3.18 | 0.67 | -4.09 | 2.99 | 0.72 | 0.72 |
Change in Other Net Operating Assets | 0.26 | -0.47 | -0.5 | 0.25 | 4.05 | -2.49 |
Operating Cash Flow | -20.13 | -17.92 | -22.3 | -23.81 | -22.99 | -22.22 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | -0 | - | - | -0.01 |
Sale (Purchase) of Intangibles | -0.21 | -0.22 | -0.23 | -0.12 | -0.39 | -0.46 |
Other Investing Activities | 0.32 | 0.2 | 0.36 | - | - | 0 |
Investing Cash Flow | 0.1 | -0.02 | 0.14 | -0.12 | -0.39 | -0.47 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 25 | 3.2 | 0.06 | 10.39 | 0.66 |
Long-Term Debt Repaid | - | -9.03 | -3.53 | -1 | -0.22 | -0.31 |
Lease Payments | -0.16 | -0.14 | -0.16 | -0.14 | -0.12 | -0.19 |
Net Debt Issued (Repaid) | 9.58 | 15.97 | -0.33 | -0.94 | 10.17 | 0.35 |
Issuance of Common Stock | 40.2 | 12.12 | 31.85 | 26.03 | 13.45 | 25.56 |
Other Financing Activities | -11.53 | -7.45 | -6.73 | -1.11 | -0.14 | -0.32 |
Financing Cash Flow | 38.25 | 20.64 | 24.79 | 23.98 | 23.48 | 25.59 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.23 | 0.11 | 0.01 | -0.17 | 0.04 | -0.15 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0 |
Net Cash Flow | 18.45 | 2.81 | 2.63 | -0.11 | 0.14 | 2.75 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -20.13 | -17.92 | -22.31 | -23.81 | -22.99 | -22.23 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.15 | -0.16 | -0.25 | -0.37 | -0.42 | -0.44 |
Levered Free Cash Flow | -12.21 | -11.34 | -17.96 | -12.86 | -12.45 | -13.55 |
Unlevered Free Cash Flow | -12.21 | -10.55 | -15.5 | -11.53 | -11.59 | -13.42 |
Free Cash Flow After Leases | -20.29 | -18.06 | -22.47 | -23.95 | -23.11 | -22.42 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.2 | 0.39 | 1.03 | 1.33 | 0.82 | 0.04 |
Cash Income Tax Paid | 0 | 0 | 0.04 | - | - | 0.02 |
Change in Working Capital | -2.91 | 0.2 | -4.6 | 3.24 | 4.77 | -1.76 |